All lobbying filings

CROSSROADS STRATEGIES, LLC

Lobbying for ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) · medical technology association

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 18, 2026

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 3

Centers For Medicare and Medicaid Services (CMS)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 2

HR 5343
Ensuring Patient Access to Critical Breakthrough Products Act
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 6

Health Issues

General education to advance policies that support innovation in the medical device industry. Issues related to coverage and reimbursement of diagnostic tests, including Issues related to FDA regulation of medical devices. Issues related to medical device sterilization. Policy issues related to the regulation of artificial intelligence for medical technology. Policies that could impact supply chain for medical technology. H.R.5343, Ensuring Patient Access to Critical Breakthrough Products Act.

Medicare/Medicaid

General education to advance policies that support innovation in the medical device industry. Issues related to the coverage and reimbursement of medical devices and technology, including AI. H.R.5343, Ensuring Patient Access to Critical Breakthrough Products Act.

Taxation/Internal Revenue Code

Issues related to R&D tax credit; Issues related to tax reform; H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation.

Trade (domestic/foreign)

Policies impacting the supply chain and manufacturing of medical devices and technology including tariffs. Issues related to reimbursement in Japan.

Budget/Appropriations

Discussions regarding implementation of medtech related provisions for FY 26.

Defense

Policies impacting third party repair of medtech.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.